相互作用
Anagrelide + Ponesimod
重症度: 重大
Anagrelide and Ponesimod: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Ponesimod slows heart rate and can affect conduction, and anagrelide can prolong QT, so the combination may raise arrhythmia risk, particularly with bradycardia. The concern is greatest in patients with existing heart disease.
この相互作用をわかりやすく説明すると
Anagrelide and Ponesimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Anagrelide belongs to Cardiovascular; Ponesimod belongs to Central Nervous System.
なぜ起こるのか
Additive effects: ponesimod-induced bradycardia increases vulnerability to anagrelide-related QT prolongation.
対処法
Obtain an ECG before starting ponesimod and seek cardiology advice if QT-prolonging drugs are required. Monitor heart rate and QTc after initiation.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、AnagrelideとPonesimodの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Anagrelideのその他の相互作用
Ponesimodのその他の相互作用
よくある質問
Can I take Anagrelide with Ponesimod?
MediHelp rates the interaction as major. Anagrelide and Ponesimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ponesimod slows heart rate and can affect conduction, and anagrelide can prolong QT, so the combination may raise arrhythmia risk, particularly with bradycardia. The concern is greatest in patients with existing heart disease.
How serious is the interaction between Anagrelide and Ponesimod?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain an ECG before starting ponesimod and seek cardiology advice if QT-prolonging drugs are required. Monitor heart rate and QTc after initiation.
What other medicines interact with Anagrelide?
MediHelp also lists interactions of Anagrelide with, for example, Panobinostat, Pimozide, Thioridazine. The full list is on the Anagrelide page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
